News

Jazz Pharma and Gentium debut Defitelio in Europe

31-03-2014

Ireland-headquartered Jazz Pharmaceuticals and its Italian subsidiary Gentium have initiated the European…

AustriaDefitelioEuropeGentiumGermanyJazz PharmaceuticalsMarkets & MarketingPharmaceuticalRare diseases

Landmark US court ruling reverses conviction on off-label drug promotion

05-12-2012

The US Court of Appeals for the Second Circuit (based in New York City) on December 3 issued a long-awaited…

Jazz PharmaceuticalsLegalMarkets & MarketingNorth AmericaPharmaceuticalRegulationXyrem

COMPANY SPOTLIGHT

Menarini

Back to top